ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype | |
Zhong Ying; Shen Songjie; Zhou Yidong; Mao Feng; Guan Jinghong; Lin Yan; Xu Yali; Sun Qiang | |
2014 | |
卷号 | 31期号:3页码:864 |
ISSN号 | 1559-131X |
DOI | 10.1007/s12032-014-0864-0 |
URL标识 | 查看原文 |
收录类别 | PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6671037 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Zhong Ying,Shen Songjie,Zhou Yidong,et al. ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype[J],2014,31(3):864. |
APA | Zhong Ying.,Shen Songjie.,Zhou Yidong.,Mao Feng.,Guan Jinghong.,...&Sun Qiang.(2014).ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype.,31(3),864. |
MLA | Zhong Ying,et al."ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype".31.3(2014):864. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论